What is the management plan for a patient on lithium carbonate (lithium) 450 mg twice daily (bid) and Latuda (lurasidone) 120 mg daily who presents with an overdose attempt?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Lithium and Lurasidone Overdose

The patient presenting with an overdose of lithium and lurasidone requires immediate supportive care, gastric decontamination, and close monitoring in a healthcare setting with consideration for hemodialysis in severe lithium toxicity.

Initial Assessment and Management

  • Check for responsiveness and activate the emergency response system immediately 1
  • Assess breathing and pulse for less than 10 seconds 1
  • If the patient is not breathing normally but has a pulse, open the airway and provide rescue breathing or bag-mask ventilation 1
  • Start high-quality CPR immediately if the patient is in cardiac arrest 1
  • Secure the airway and consider endotracheal intubation if respiratory status is compromised 2

Specific Management for Lithium Toxicity

  • No specific antidote exists for lithium poisoning 3
  • Implement gastric lavage to reduce further absorption if the patient presents within 1-2 hours of ingestion 3
  • Correct fluid and electrolyte imbalances with IV fluids 3
  • Monitor kidney function closely as lithium is primarily eliminated through the kidneys 3
  • Obtain serum lithium levels immediately and serially to guide management 3
  • Consider hemodialysis for patients with:
    • Severe lithium toxicity (levels >3.0 mEq/L)
    • Signs of neurotoxicity despite lower levels
    • Significant renal impairment
    • Deteriorating clinical status despite supportive care 3

Management for Lurasidone Overdose

  • There is no specific antidote for lurasidone overdose 2
  • Provide supportive care with close monitoring of vital signs 2
  • Monitor for potential extrapyramidal symptoms, which may require treatment with anticholinergic medications 4
  • Be aware that lurasidone has minimal effects on QTc interval compared to other antipsychotics, but ECG monitoring is still recommended 5
  • Watch for potential drug interactions, as lurasidone is metabolized by CYP3A4 6

Monitoring and Supportive Care

  • Continuously monitor vital signs, mental status, and cardiac rhythm 1
  • Check electrolytes, renal function, and complete blood count 3
  • Monitor for signs of lithium neurotoxicity, which can occur even with therapeutic lithium levels when combined with antipsychotics 7
  • Watch for signs of serotonin syndrome if the patient is on other serotonergic medications 2
  • Provide infection prophylaxis and regular chest X-rays as needed 3

Disposition and Follow-up

  • Patients should be observed in a healthcare setting until the risk of recurrent toxicity is low and vital signs have normalized 1
  • Longer observation periods are required for lithium overdose due to its delayed absorption and distribution characteristics 3
  • Psychiatric evaluation is essential before discharge to assess suicide risk and adjust treatment plan 8
  • Consider alternative medication regimens if the overdose was intentional 8

Common Pitfalls to Avoid

  • Don't underestimate the toxicity of lithium, as therapeutic levels are close to toxic levels 3
  • Don't discharge patients too early, as lithium toxicity can have delayed onset 3
  • Be aware that the combination of lithium and antipsychotics like lurasidone can increase the risk of neurotoxicity 7
  • Don't focus solely on one drug when managing this polysubstance overdose 2
  • Recognize that stable vital signs can deteriorate rapidly in overdose situations 2

References

Guideline

Initial Management of Drug Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Drug Overdose Not Responding to Naloxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of bipolar I depression: clinical utility of lurasidone.

Therapeutics and clinical risk management, 2015

Research

Lurasidone drug-drug interaction studies: a comprehensive review.

Drug metabolism and drug interactions, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.